financetom
Business
financetom
/
Business
/
Cisco raises full-year revenue forecast
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cisco raises full-year revenue forecast
Feb 12, 2025 1:29 PM

Feb 12 (Reuters) - Cisco Systems ( CSCO ) raised its

annual revenue forecast on Wednesday, betting on higher demand

for its cloud networking gear amid a boom in the artificial

intelligence technology.

The company expects its revenue to be between $56 billion

and $56.5 billion for fiscal 2025, compared with its prior

forecast of $55.3 billion to $56.3 billion.

Analysts, on average, expect $55.99 billion, according to

data compiled by LSEG.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Catalent Acquisition by Novo Holdings Nearly Complete After Regulatory Hurdles Cleared
Catalent Acquisition by Novo Holdings Nearly Complete After Regulatory Hurdles Cleared
Dec 16, 2024
07:11 AM EST, 12/16/2024 (MT Newswires) -- Catalent ( CTLT ) and Novo Nordisk's ( NVO ) parent company Novo Holdings said Monday that they have completed all regulatory closing conditions for Novo's pending acquisition of Catalent ( CTLT ). The deal to take Catalent ( CTLT ) private under Novo is now expected to close in the coming days,...
Phillips 66 forecasts lower 2025 spending in refining unit
Phillips 66 forecasts lower 2025 spending in refining unit
Dec 16, 2024
Dec 16 (Reuters) - U.S. refiner Phillips 66 on Monday forecast slightly lower spending in 2025, as it expects decreased disbursement in its core refining segment. U.S. refining margins are expected to stabilize next year, according to data from the Energy Information Administration, backed by an uptick in industrial demand and refinery closures, including Phillips 66's Los Angeles area plant....
Merck's KEYTRUDA Approved in Combination With Chemotherapy in China to Treat Lung Cancer
Merck's KEYTRUDA Approved in Combination With Chemotherapy in China to Treat Lung Cancer
Dec 16, 2024
07:14 AM EST, 12/16/2024 (MT Newswires) -- Merck & Co ( MRK ) said Monday that its anti-PD-1 therapy, KEYTRUDA, has been approved by the National Medical Products Administration in China in combination with chemotherapy to treat certain patients with non-small cell lung cancer. KEYTRUDA was previously approved in combination with chemotherapy in the US in October 2023 based on...
BRIEF-The Shyft Group To Merge With Aebi Schmidt Group To Create A Specialty Vehicles Leader
BRIEF-The Shyft Group To Merge With Aebi Schmidt Group To Create A Specialty Vehicles Leader
Dec 16, 2024
Dec 16 (Reuters) - Shyft Group Inc ( SHYF ): * THE SHYFT GROUP TO MERGE WITH AEBI SCHMIDT GROUP TO CREATE A SPECIALTY VEHICLES LEADER Source text: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved